Satellos Bioscience
Cash Flow

Last updated:

Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Satellos Bioscience generated cash of -$5,713,347, which is less than the previous year. Cash used in financing activities reached the amount of $2,774,912 last year. Net change in cash is therefore -$2,947,727.

Cash Flow

Satellos Bioscience Inc. (TSX:MSCL.V): Cash Flow
2019 -2.23M -5.99K 3.21M
2020 -1.65M 0 1.97M
2021 -5.03M 1.73M 7.45M
2022 -5.71M -3.46K 2.77M

MSCL.V Cash Flow Statement (2019 – 2022)

2022 2021 2020 2019
Cash at beginning of period
4.87M717.53K399.12K0
Operating activities
Net income
-11.32M-15.50M-1.57M-1.93M
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
336.94K165.68K422-3.06K
Stock-based compensation expense
1.43M971.53K88.60K0
Deferred income tax benefit 1.43M971.53K88.60K0
Changes in operating assets and liabilities:
Accounts receivable, net
1.78K40.12K-29.40K-284.18K
Inventories
-726.11K390.47K444.85K0
Accounts payable
726.11K-390.47K-444.85K0
Cash generated by operating activities
-5.71M-5.03M-1.65M-2.23M
Investing activities
Purchases Of Investments
0000
Investments In Property Plant And Equipment
-3.46K-7.24K0-5.99K
Acquisitions Net
01.74M00
Cash generated by investing activities
-3.46K1.73M0-5.99K
Financing activities
Common Stock Issued
1.99M7.07M890.54K3.21M
Payments for dividends
0000
Repurchases of common stock
0000
Repayments of term debt
0-186.57K-1.08M0
Cash used in financing activities
2.77M7.45M1.97M3.21M
Net Change In Cash
-2.94M4.15M318.40K973.76K
Cash at end of period
1.92M4.87M717.53K973.76K